Connect with us

News

NHS makes fresh uptake appeal as five million women not up to date with cervical screening

Published

on

Women are being urged to come forward for cervical screening as new figures show more than five million are not up to date with their routine check-ups.

The NHS invites women for screening every three to five years depending on their age, or more frequently if the high-risk human papillomavirus (HPV) is detected, with the programme saving thousands of lives annually.

The NHS Cervical Screening Programme, England 2023-2024 annual report found that 68.8 per cent of 25 to 64-year-olds were screened within the recommended period of time, compared to 68.7 per cent the previous year.

Coverage was higher for 50 to 64-year-olds at 74.3 per cent compared with 25 to 49-year-olds at 66.1 per cent.

In 2023-24, everyone who was due a test – a total of 5.12 million individuals aged 25 to 64 in England – was invited to book an appointment, and 3.25 million were tested during the year.

Last year, the NHS pledged to eliminate cervical cancer by 2040 by making it as easy as possible for people to get the lifesaving HPV vaccination and encouraging more women and people with a cervix to come forward for their cervical screening.

Earlier this month, the NHS set out reforms to fully digitise screening – by announcing the rollout of a new “ping and book” service that will send alerts to phones to remind women they are due or overdue an appointment.

The plans will begin with invitations for breast screening being sent directly through the NHS App, and be expanded to include cervical screening in Spring 2025.

NHS cervical screening helps prevent cervical cancer by using a highly effective test to check for HPV, which is found in over 99 per cent of all cervical cancers and which may cause abnormal cells to develop in the cervix. These abnormal cells can, over time, turn into cancer if left untreated.

Women who are due a cervical screening appointment will receive invitation letters by post when it’s time to book. Appointments can be booked through GP practices and some sexual health clinics also offer the service. A

nyone who has previously received an invitation and been unable to attend shouldn’t wait for another invitation – you can still book a cervical screening appointment even if invited weeks, months or years ago.

Sue Mann, NHS England’s National Clinical Director for Women’s Health, said: “We have set ourselves an ambitious target of eliminating cervical cancer by 2040 – a commitment shared by only a few countries worldwide.

“In order to achieve this, we are working hard to ensure that everyone who’s eligible has access to HPV vaccination and cervical screening appointments, and that they are suitably informed on how to book and what to expect at an appointment.

“If we are to make real inroads into eradicating cervical cancer, it’s essential that everyone who is invited for screening comes forward when invited.

“If you have previously missed your appointment, do not hesitate to reach out to your GP practice or sexual health clinic to schedule a new one. Taking this proactive step could potentially save your life.”

Sophia Lowes, Senior Health Information Manager at Cancer Research UK, said: “Cervical screening saves thousands of lives every year in the UK.

“It’s for people without symptoms and helps to prevent cervical cancer from developing in the first place.

“Cancer Research UK encourages everyone who receives an invitation to take part.

“Some people may have found cervical screening uncomfortable in the past or have experienced other barriers to taking part.

“But there are things you can ask for to help you feel more comfortable, such as asking for a nurse of a specific gender or asking for a smaller speculum – the tool that nurses use to look at your cervix.

“You can also ask for a longer appointment so you can talk through any concerns with the nurse on what adjustments you might need.

“On top of this, the NHS in England is taking steps to make it easier to take part in cervical screening, such as letting you book your appointment through the NHS App.

“In the future, innovations like HPV self-sample kits, which allow people to collect a sample for testing themselves, could help more people take part.

“We’re looking forward to seeing the impact these new initiatives could have.”

England is among the first countries in the world to set the elimination ambition for cervical cancer within the next two decades.

The World Health Organization considers cervical cancer to be eliminated as a public health problem when there is an incidence rate lower than four per 100,000 women.

News

Only one-in-three voters say US healthcare system meeting women’s needs

Published

on

Only 31 per cent of US voters believe healthcare does a good job of meeting women’s needs, according to a national survey.

The survey found broad agreement that women have distinct health needs requiring specific attention, but that care falls short at several stages of life.

Impact Research and Echelon Insights conducted the survey for Center Forward among 1,206 registered voters in the likely electorate across the US.

Tara Evans, marketing director for Plan B One-Step, said: “These findings should serve as a wake-up call for the health care industry and for policymakers.

“Women are telling us loudly and clearly that the system is not working for them. From reproductive health to menopause care to postpartum support, the gaps are real, they are significant, and voters want action.”

Only 31 per cent of respondents said the healthcare system did a good or very good job of meeting women’s health needs.

This compared with 41 per cent who said it performed well in meeting men’s health needs.

Half of the women surveyed said the system did not pay enough attention to their health issues.

Some 41 per cent rated the system as poor or very poor at meeting women’s needs immediately before, during and after menopause.

A further 38 per cent gave the same rating for care following pregnancy and during the postpartum period.

The figure was 35 per cent for care provided while women were seeking to prevent pregnancy.

Overall, 92 per cent agreed that women have distinct health needs deserving specific attention, including 89 per cent of Republicans and 95 per cent of Democrats.

Access to screening for cancers affecting women was considered very important for policymakers to address by 81 per cent of respondents.

Prenatal care was prioritised by 78 per cent, while 77 per cent highlighted both gynaecological care and cardiovascular services.

Postpartum care was considered very important by 72 per cent, while 68 per cent said the same about diabetes and weight management services.

Some 46 per cent of voters said the healthcare system did a poor or very poor job of meeting the needs of rural patients.

Rural women were six percentage points more likely than voters overall to report difficulty accessing quality care.

The findings also showed that gaps in care were not evenly distributed.

Women who described their health as fair or poor were 15 percentage points more likely than those in excellent or very good health to say the system paid too little attention to their needs.

People earning less than US$50,000 a year were among those most likely to feel overlooked.

Among voters earning between US$30,000 and US$49,000 annually, 61 per cent said the system did not pay enough attention to their health issues.

Evans said: “The picture this data paints is one of a system that works better for some Americans than others, and women, particularly those with lower incomes or in rural communities, are bearing the greatest burden of that failure.

“Plan B is committed to being part of the solution by ensuring that at the very minimum, women have access to emergency contraception when they need it.”

Plan B One-Step is an over-the-counter emergency contraceptive available in all 50 US states without identification or a prescription.

The company says it donates up to 500,000 units each year to clinics, non-profit organisations, advocacy groups and other qualifying organisations supporting medically underserved communities.

The survey was conducted from 12 to 16 January 2026 and had a margin of sampling error of plus or minus 3.2 percentage points.

Plan B One-Step is a backup form of birth control intended to help prevent pregnancy after unprotected sex or when another contraceptive method fails.

It is not an abortion pill and does not affect implantation or harm an existing pregnancy.

Emergency contraception such as Plan B is used within 72 hours of unprotected sex and works better the sooner it is taken.

The findings form part of the 2026 Women’s Health Mandate, a five-part bipartisan series examining women’s healthcare in the US.

Continue Reading

Pregnancy

New reporting tool targets maternal-fetal teams as pregnancy complexity rises

Published

on

A new reporting tool built specifically for obstetrics and maternal-fetal medicine has launched, aimed at teams managing increasingly complex pregnancies with limited time and resources.

Trice Imaging has released Trice Workspace Reporting, which connects imaging, reporting and longitudinal patient data in a single workflow to support faster clinical decision making.

Birth rates are falling worldwide, but pregnancies are getting more complicated. Advanced maternal age, IVF-assisted pregnancies, rising obesity rates and a higher prevalence of hypertension and diabetes mean more cases now require specialist monitoring, advanced imaging and multidisciplinary care.

At the same time, clinical teams are stretched and facing growing administrative demands.

Trice Workspace Reporting brings together customisable reporting, dynamic pregnancy dating and longitudinal patient history with an AI-ready, EHR-interoperable infrastructure, all inside the company’s Tricefy image management platform.

The company says it aims to accelerate standardised and synchronised report turnaround, support timely clinical decisions and improve operational efficiency for fetal medicine services.

“Maternal fetal medicine teams are managing increasingly complex pregnancies while being asked to do more with limited time and resources,” said Mark A. Samii, chief revenue officer at Trice Imaging.

“Trice Workspace Reporting is designed to remove unnecessary friction from reporting by creating a structured digital foundation that supports today’s need for connected clinical workflows.

“It also provides a digital foundation as practices prepare for tomorrow and the evolution of AI-enabled fetal assessment, anomaly detection and outcome prediction technologies.”

Trice Imaging describes its mission as transforming the women’s health journey by connecting physicians, patients and healthcare systems. From independent practices to large hospital ecosystems, it aims to reach the entire women’s health continuum, spanning IVF and reproductive health, maternal-fetal medicine and OB/GYN, and onwards to lifelong women’s health.

For more than 17 years the firm has worked on cloud-based storage, retrieval, display, organisation and exchange of ultrasound medical images and associated information across health environments.

Its wider platform now extends to dynamic clinical reporting, AI-driven workflow optimisation, data analytics and secure patient engagement.

Trice Imaging holds regulatory and data protection clearances in 40 countries. It has offices in Miami and Stockholm, alongside a growing network of global distributors.

Continue Reading

News

Vespexx signs MOU with global femtech network Femtech Across Borders

Published

on

Vespexx, the femtech company behind couples preconception health platform Soonr, has signed a memorandum of understanding (MOU) with Femtech Across Borders, a global femtech network supporting women’s health initiatives across 80 countries.

The agreement was signed on June 30 at Korea Femtech Summit 2026, the first global femtech summit held in Korea, hosted by Vespexx.

Femtech Across Borders is a global femtech community led by founder Rachel Bartholomew, who entered the field after her own battle with cervical cancer.

The organisation connects women’s health innovators, companies, and institutions worldwide, supporting collaboration across borders.

“For Korean femtech to reach the world, connection with the global community matters more than anything,” said Scarlett Joowon Jung, co-CEO of Vespexx.

“Through our collaboration with Femtech Across Borders, we’ll continue to strengthen our role as a bridge between Korea and the global femtech community.”

Through the MOU, the two parties will work to lower the barriers between Korean and global femtech, raising awareness of women’s health, sharing networks, and exploring future opportunities to collaborate.

Vespexx, in particular, intends to serve as a bridge connecting Korean femtech companies with the global community, widening the path for domestic companies to reach international markets.

The agreement builds on Vespexx’s recent global momentum.

On June 30, the company hosted Korea Femtech Summit 2026, bringing together femtech leaders from Korea and abroad, and used the occasion to announce the launch of Femtech Korea, an industry network that brings Korean femtech companies together and connects them with the world.

The partnership with Femtech Across Borders extends that effort outward, linking Korea’s domestic network to the global community.

Learn more about Vespexx at vespexx.com

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.